Abstract
Background. SARS-CoV-2 (COVID-19) and influenza A(H1N1)pdm09 are associated with the development of viral pneumonia and acute respiratory distress syndrome (ARDS), contributing to high mortality. Differences in clinical and radiological characteristics of lung involvement in these infections require further investigation. Objective. To determine the clinical and radiological features of lung involvement in patients with COVID-19 and influenza A(H1N1)pdm09 complicated by communityacquired pneumonia, and to assess the correlation between the extent of lung parenchymal involvement and disease severity. Materials and Methods. A total of 113 medical records from 2021–2023 were analyzed: 75 patients with COVID-19, 38 with other viral pneumonias, and 30 with influenza A(H1N1)pdm09 (2009–2016). The extent of lung involvement was assessed using the RALE score and CT-based criteria (CT-1–CT-4). Results. In patients with COVID-19, bilateral lung involvement was observed in 92.3% of cases, peripheral distribution of infiltrates in 59%, and ground-glass opacities in all patients. Consolidations were detected in 43.5% of cases. In patients with influenza A(H1N1)pdm09 and other viral pneumonias, imaging findings were similar but predominantly peribronchovascular in distribution. No reversed halo sign or cavitation was observed. The RALE score ranged from 9 to 48 points (mean 29 ± 3.707). No correlation was found between RALE score and disease duration. No association was identified between the extent of lung involvement and COVID-19 severity. Conclusions. The findings indicate differences in radiological patterns of lung involvement between COVID-19 and influenza A(H1N1)pdm09. The RALE score is an effective tool for standardized assessment of disease severity.

This publication has 25 references indexed in Scilit: